Tesaro, Inc. develops and commercializes cancer therapeutics and supportive care products. The Company offers receptor antagonist for the prevention of chemotherapy induced nausea and vomiting. Tesaro operates in the United States.
more
Refresh
No publications yet
Add Tesaro Inc to your Watchlist to get alerts on new publications